Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Clinical Research, Pharmaceuticals, BiotechnologyIndustries

Requirements

A Master's or PhD in Statistics, Biostatistics, or a related field is required, though a Bachelor's degree with substantial biostatistics experience will be considered. Candidates must have at least 2 years of biostatistics experience, preferably in clinical trials, and proficiency in statistical software like SAS, R, or Python. Experience in life sciences, regulatory environments, and knowledge of 21 CFR Part 11 and GxP are highly preferred. Strong statistical knowledge, including survival analysis, mixed models, and longitudinal data analysis, is essential, along with excellent problem-solving abilities, attention to detail, and strong written and verbal communication skills.

Responsibilities

The Biostatistician will provide statistical expertise in the design and analysis of clinical trials, develop and author Statistical Analysis Plans (SAPs), and contribute to study randomization. They will review clinical trial protocols, analyze clinical trial data using advanced statistical techniques, and collaborate with Statistical Programmers to validate data sets and statistical outputs. Responsibilities also include reviewing and signing off on study documents and data management deliverables, providing programming support for analyses, staying current with regulatory guidelines, and representing biostatistics on project teams.

Skills

Biostatistics
Clinical Trials
Statistical Analysis
Statistical Analysis Plans (SAPs)
Randomization
Statistical Methodologies
Data Analysis
SAS
R
Statistical Programming
Regulatory Guidelines
Protocol Development

Endpoint Clinical

Provides interactive response technology for clinical trials

About Endpoint Clinical

Endpoint Clinical provides interactive response technology (IRT) systems designed for clinical trials. Their systems assist with various trial processes such as managing drug supplies, randomizing patients, and scheduling visits. These systems are user-friendly and cater to clients in the life sciences sector, including pharmaceutical and biotechnology companies. Endpoint Clinical differentiates itself by focusing on ease of use and integration with other clinical trial management systems, ensuring that clients can streamline their processes and maintain regulatory compliance. The company's goal is to enhance the efficiency and transparency of clinical trials, allowing sponsors to conduct their research more effectively.

San Francisco, CaliforniaHeadquarters
2009Year Founded
$1.7MTotal Funding
DEBTCompany Stage
Enterprise Software, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options

Risks

Emerging IRT providers with cost-effective solutions threaten Endpoint Clinical's market share.
Rapid AI advancements may outpace Endpoint Clinical's current technology offerings.
Decentralized trials could reduce demand for traditional IRT systems, impacting Endpoint's model.

Differentiation

Endpoint Clinical offers user-friendly IRT systems for clinical trial management.
The company specializes in drug supply management, patient randomization, and visit scheduling.
Endpoint Clinical collaborates with THREAD and Berlinger for integrated clinical trial solutions.

Upsides

Increased adoption of DCTs boosts demand for flexible IRT systems like Endpoint Clinical's.
AI integration in clinical trials offers Endpoint opportunities for advanced analytics.
Personalized medicine trends require sophisticated IRT solutions, benefiting Endpoint Clinical.

Land your dream remote job 3x faster with AI